Stability studies showed that the batch does not meet quality requirements (result above the limit for free hydrocortisone content), which according to the authority constitutes a real and direct threat to patients’ health or life. Potential effects: impaired treatment efficacy, unpredictable adverse reactions, complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use product from batch 110021, check the batch number on the packaging and return the medicine to the pharmacy or consult a doctor if in doubt.
Distribution of the medicinal product Corhydron 25 batch 110021 was suspended throughout the country and the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related